|
PPD Korea |
[PPD] ä¿ë°ø°í - Principal Regulatory Affairs Specialist
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
8³â¡è |
ä¿ë½Ã |
03.03 |
|
|
(ÁÖ)Çʷνýº |
ºÎ¼³¿¬±¸¼Ò ¿¬±¸¼ÒÀå ä¿ë
°æ±â ¼º³²½Ã ºÐ´ç±¸ | ´ëÇпø(¹Ú»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
11.23 |
|
|
ÇÇÇǾ¾ÄÚ¸®¾Æ(ÁÖ) |
[PPC Korea] Finance Manager ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
5³â¡è |
ä¿ë½Ã |
05.06 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Regulatory Officer / Senior Regulatory O
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
05.04 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA I/II (Lead Monitor Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
05.04 |
|
|
(ÁÖ)¿À·¡¿Â¶óÀÌÇÁ»çÀ̾𽺠|
[Á¤±ÔÁ÷] B2B ¿µ¾÷ °æ·Â ä¿ë
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
11.29 |
|
|
(ÁÖ)Çѱ¹ºñ¿£¾¾ |
CEÀÎÁõ/Çؿܵî·Ï/ÀÎÇã°¡(RA) °æ·ÂÀÚ Ã¤¿ë °ø°í
¼¿ï ±¸·Î±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
10³â¡è |
ä¿ë½Ã |
04.26 |
|
|
Æĸ¶¸®¼Ä¡ |
Biomaterials Part ¿¬±¸¿ø ¸ðÁý
°æ±â ¼º³²½Ã ¼öÁ¤±¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
09.21 |
|
|
¿¡½ºµð¹ÙÀÌ¿À¼¾¼(ÁÖ) |
ºòµ¥ÀÌÅÍ °³¹ßÀÚ/Àü±âÈÇм¾¼ °³¹ßÀÚ ¸ðÁý
°æ±â ¼ö¿ø½Ã ¿µÅ뱸 | ´ëÇÐ(4³â) Á¹¾÷ |
ÇϹݱ⠻ç¿ø¸ðÁý |
5³â¡è |
ä¿ë½Ã |
04.09 |
|
|
¿¬¼ºÁ¤¹ÐÈÇÐ(ÁÖ) |
[¿¬¼ºÁ¤¹ÐÈÇÐ °è¿] ¿ÍÀÌ¿¡½º»ý¸í°úÇÐ ºÎ¹®º° ä¿ë °ø°í
°æ±â ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
5³â¡è |
ä¿ë½Ã |
04.12 |
|
|
»ý°í¹ðÄÚ¸®¾Æ ÁÖ½Äȸ»ç |
°ø¹«ÆÀ °æ·Â»ç¿ø ¸ðÁý
ÀÎõ ÀüÁö¿ª | Çз¹«°ü |
°ø¹«/Àü±â/±â°è |
8³â¡è |
ä¿ë½Ã |
04.08 |
|
|
(ÁÖ)ºñ¾ØºñÇコÄɾî |
°æ¸®/ȸ°è/ÀÎ»ç °æ·ÂÁ÷¿ø ¸ðÁý
°æ±â ¼º³²½Ã Áß¿ø±¸ | Çз¹«°ü |
À繫/ȸ°è/IR/ÀÚ±Ý/°¨»ç |
5³â¡è |
ä¿ë½Ã |
05.03 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA II (Regional Lead Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
7³â¡è |
ä¿ë½Ã |
03.29 |
|
|
ÈÞÁ©(ÁÖ) |
[ÄÁÅÙÃ÷°³¹ßÆÀ] Medical Support °æ·Â
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ó¹Ý±â »ç¿ø¸ðÁý |
5³â¡è |
ä¿ë½Ã |
|
|
|
(ÁÖ)¿¤¿¡½ºÄÉÀ̱۷ιúÆĸ¶¼ºñ½º |
SCºÎ¼ RA °æ·Â ä¿ë
¼¿ï Áß±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
5³â¡è |
ä¿ë½Ã |
12.05 |
|